Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemokines and angiogenesis.

Z Szekanecz1, A E Koch

  • 1Third Department of Medicine, University of Debrecen Medical and Health Sciences Center, Debrecen, Hungary. szekanecz@iiibel.dote.hu

Current Opinion in Rheumatology
|May 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Seminars in arthritis and rheumatism·2022
Same author

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial.

Scandinavian journal of rheumatology·2019
Same author

Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.

Lupus·2018
Same author

Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Annals of the rheumatic diseases·2016
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Chemokines and angiogenesis are key drivers in rheumatoid arthritis pathogenesis. Understanding their roles offers potential for novel therapeutic interventions targeting inflamed synovium and neovascularization.

Area of Science:

  • Immunology
  • Rheumatology
  • Vascular Biology

Background:

  • Rheumatoid arthritis (RA) involves leukocyte infiltration into the synovium.
  • Chemokines (C-X-C and C-C families) are critical for this inflammatory cell recruitment.
  • Angiogenesis, the formation of new blood vessels, also contributes significantly to RA pathogenesis.

Purpose of the Study:

  • To review the role of key chemokines in rheumatoid synovitis.
  • To discuss important angiogenic factors and inhibitors in rheumatoid arthritis.
  • To explore the interplay between chemokines and angiogenesis in RA, including neovascularization.

Main Methods:

  • Literature review focusing on chemokine function and angiogenesis in rheumatoid arthritis.
  • Analysis of existing research on the pathogenic roles of these factors.

Related Experiment Videos

  • Synthesis of information regarding therapeutic implications.

    • Main Results:

    • Specific C-X-C and C-C chemokines are crucial for leukocyte migration in RA.
    • Various angiogenic factors and inhibitors are implicated in the disease process.
    • Chemokines can influence neovascularization, linking them directly to angiogenesis in RA.

    Conclusions:

    • Chemokines and angiogenesis are central to rheumatoid synovitis pathogenesis.
    • These processes represent significant targets for therapeutic strategies in rheumatoid arthritis.
    • Further research into the chemokine-angiogenesis axis may yield innovative treatments.